Palvella Therapeutics PVLA
NASDAQ PVLA
$123.92 +0.96 (+0.78%)
At close: Oct 20, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) EV to EBIT (2024)

Updated

Palvella Therapeutics' (PVLA) EV to EBIT was 0.68 for Q3 2024.

Analysis

Palvella Therapeutics (PVLA) EV to EBIT (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Palvella Therapeutics 1.77 Bn 1.52 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 0.68
Mar 31, 2024 0.12
API Access

Palvella Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=PVLA&period=max&api_key=YOUR_API_KEY